Keywords: خط اول درمان; acne inversa; first-line treatment; hidradenitis suppurativa; increased age; medical therapy; patient response; smoking; CI; confidence interval; EMR; electronic medical record; HS; hidradenitis suppurativa; OR; odds ratio;
مقالات ISI خط اول درمان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: خط اول درمان; First-line treatment; Kidney cancer; mRCC; Phase II; VEGFR inhibitor;
Keywords: خط اول درمان; Active SSc-ILD; First-line treatment; Second-line treatment
Keywords: خط اول درمان; First-line treatment; HER2 and HR status; Metastatic breast cancer; Systematic review and meta-analysis; Targeted therapy;
Keywords: خط اول درمان; First-line treatment; hormone therapy; locally advanced; prostate cancer; prostate neoplasm; radiotherapy;
Endocrine therapy or chemotherapy as first-line therapy in hormone receptor-positive HER2-negative metastatic breast cancer patients
Keywords: خط اول درمان; Hormone receptor-positive HER2-negative metastatic breast cancer; Aromatase inhibitor-sensitive; First-line treatment;
Original StudyFirst-Line PAzopanib in NOn-clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA Study
Keywords: خط اول درمان; Chromophobe RCC; First-line treatment; nccRCC; Papillary RCC; Pazopanib;
Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies
Keywords: خط اول درمان; Adverse events; Cross-trial analysis; First-line treatment; Post-hoc analysis; Treatment duration;
Axitinib Versus Sorafenib in First-Line Metastatic Renal Cell Carcinoma: Overall Survival From a Randomized Phase III Trial
Keywords: خط اول درمان; Eastern Cooperative Oncology Group performance status; First-line treatment; Randomized phase III trial; Tyrosine kinase inhibitor; VEGF receptor inhibitor;
Effect of RAS status on anti-EGFR monoclonal antibodies + 5-FU infusion-based chemotherapy in first-line treatment of metastatic colorectal cancer: A meta-analysis
Keywords: خط اول درمان; Metastatic colorectal cancer; First-line treatment; Ras mutation; Monoclonal antibodies; Meta-analysis;
SUCCINCT: An Open-label, Single-arm, Non-randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-line Treatment for Patients with Advanced Urothelial Carcinoma
Keywords: خط اول درمان; Advanced urothelial tract transitional cell carcinoma; Phase 2; Clinical trial; First-line treatment; Sunitinib;
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments
Keywords: خط اول درمان; CLL; Bendamustine; Rituximab; Elderly patients; First-line treatment;
Phase II study of a combination regimen of gefitinib and pemetrexed as first-line treatment in patients with advanced non-small cell lung cancer harboring a sensitive EGFR mutation
Keywords: خط اول درمان; Non-small cell lung cancer; Epidermal growth factor receptor; Gefitinib; Pemetrexed; Phase II study; First-line treatment;
Quel traitement de première ligne en cas de mutation activatrice de l'EGFR dans les cancers bronchiques non à petites cellules (CBNPC) disséminés ?
Keywords: خط اول درمان; Mutation activatrice de l'EGF-R; CBNPC non épidermoïde; Addiction oncogénique; Résistance secondaire; Traitement de première ligne; TKI de l'EGF-R; Afatinib; Erlotinib; Gefitinib; Activating mutation of EGF-R; Non-squamous cell NSCLC; Oncogenic a
The Mammotome biopsy system is an effective treatment strategy for breast abscess
Keywords: خط اول درمان; Breast abscess; Mammotome biopsy system; First-line treatment
Early Response to Chemotherapy in Patients With Non–Small-Cell Lung Cancer Assessed by [18F]-Fluoro-Deoxy-D-Glucose Positron Emission Tomography and Computed Tomography
Keywords: خط اول درمان; Antiangiogenic therapy; First-line treatment; Objective response; Positron emission tomography (PET); Sorafenib
A Randomized Phase II Study of Pemetrexed in Combination With Cisplatin or Carboplatin as First-Line Therapy for Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer
Keywords: خط اول درمان; First-line treatment; Nonsquamous histology; Pemetrexed; Platinum combinations; Stage IIIB/IV non–small-cell lung cancer
Influence of histology and biomarkers on first-line treatment of advanced non-small cell lung cancer in routine care setting: Baseline results of an observational study (FRAME)
Keywords: خط اول درمان; Advanced or metastatic NSCLC; Routine practice setting; First-line treatment; Biomarkers; Histology; Observational study
Treatment Decisions After Diagnosis of Metastatic Colorectal Cancer
Keywords: خط اول درمان; Bevacizumab; Cetuximab; First-line treatment; KRAS mutation; Panitumumab
Quelle est la meilleure séquence thérapeutique chez les patients ayant un CBNPC avec mutation activatrice de l'EGFR ?
Keywords: خط اول درمان; Cancer bronchique; Mutation EGFR; Inhibiteur tyrosine kinase; Première ligne; Non small cell lung cancer; EGFR mutation; Tyrosine kinase inhibitors; First-line treatment;
Effect of gefitinib challenge to initial treatment with non-small cell lung cancer
Keywords: خط اول درمان; Gefitinib; Non-small-cell lung cancer (NSCLC); First-line treatment
Docetaxel Vs. Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: A Hellenic Oncology Research Group Randomized Phase III Study
Keywords: خط اول درمان; Docetaxel; Elderly patients; First-line treatment; Non–small-cell lung cancer (NSCLC); Phase III study; Vinorelbine
Gefitinib as First-line Treatment in Elderly Epidermal Growth Factor Receptor-mutated Patients With Advanced Lung Adenocarcinoma: Results of a Nagano Lung Cancer Research Group Study
Keywords: خط اول درمان; EGFR mutation; Elderly patients; First-line treatment; Gefitinib; Lung adenocarcinoma;
Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating Epidermal Growth Factor Receptor mutation: Implications for clinical practice and open issues
Keywords: خط اول درمان; Gefitinib; Advanced NSCLC; First-line treatment; EGFR mutation;
Analysis for Prognostic Factors of 60-day Mortality: Evaluation of an Irinotecan-Based Phase III Trial Performed in the First-Line Treatment of Metastatic Colorectal Cancer
Keywords: خط اول درمان; 60-day mortality; Colorectal cancer; First-line treatment; Irinotecan; Oxaliplatin; Prognostic factors
Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer
Keywords: خط اول درمان; Metastatic colorectal cancer; First-line treatment; Chemotherapy; 5-Fluorouracil; Irinotecan; Oxaliplatin; Phase III
Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence
Keywords: خط اول درمان; Gefitinib; Advanced NSCLC; First-line treatment; EGFR mutation
Cutaneous lupus erythematosus: Update of therapeutic options : Part I
Keywords: خط اول درمان; antimalarials; first-line treatment; lupus erythematosus; photoprotection; skin; smoking; sunscreens; treatmentCLE, cutaneous lupus erythematosus; CS, corticosteroids; DLE, discoid lupus erythematosus; LE, lupus erythematosus; LET, lupus erythematosus tum
Emerging profile of cetuximab in non-small cell lung cancer
Keywords: خط اول درمان; Advanced NSCLC; First-line treatment; Cetuximab; Biologic therapy; Survival
Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: Long-term results
Keywords: خط اول درمان; First-line treatment; Radiofrequency ablation; Hepatocellular carcinoma; Survival
Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: Results from a prospectively designed analysis of prog
Keywords: خط اول درمان; Interferon γ-1b; Carboplatin; Paclitaxil; First-line treatment; Advanced ovarian; Primary peritoneal carcinomas
How Urologists Manage Erectile Dysfunction after Radical Prostatectomy: A National Survey (REPAIR) by the French Urological Association
Keywords: خط اول درمان; First-Line Treatment; On Demand; Intracavernous Injections; PGE1; Rehabilitation; Practice; Sexual Activity;
Sequential gemcitabine–carboplatin followed by paclitaxel–carboplatin in the first-line treatment of advanced ovarian cancer: A phase II study
Keywords: خط اول درمان; Sequential chemotherapy; Gemcitabine; Carboplatin; Paclitaxel; First-line treatment; Ovarian cancer
Capecitabine plus oxaliplatin (xelox) versus protracted 5-fluorouracil venous infusion plus oxaliplatin (pvifox) as first-line treatment in advanced colorectal cancer: A GOAM phase II randomised study (FOCA trial)
Keywords: خط اول درمان; XELOX; Pvi-FU; Advanced colorectal cancer; First-line treatment; Capecitabine; Oxaliplatin
Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: Pathologic complete response and longitudinal assessment of impact on cognitive functioning
Keywords: خط اول درمان; Ovarian; Neoplasms; First-line treatment; Chemotherapy; Advanced disease; Paclitaxel; Gemcitabine; Carboplatin; Quality-of-life; Cognitive functioning
Observatoire national des premières instaurations d'un traitement anti-épileptique (OPIA)
Keywords: خط اول درمان; Ãpilepsie; Traitement anti-épileptique; Patients nouvellement traités; Ãtude prospective; Epilepsy; Anti-epileptic treatment; First-line treatment; Prospective study;
Single-Agent Gefitinib in Patients with Untreated Advanced Non-Small-Cell Lung Cancer and Poor Performance Status: A Minnie Pearl Cancer Research Network Phase II Trial
Keywords: خط اول درمان; First-line treatment; Multicenter trial; Quality of life; Stage IIIB/IV disease;
A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer
Keywords: خط اول درمان; Pemetrexed; Vinorelbine; Non-small cell lung cancer; First-line treatment; MTD; Pharmacokinetics; Tumor response;